Miriam Martin joined TFS in 2009 and currently serves as Vice President of Business Development, Clinical Development Services (CDS). In this role, she leads global business development strategies and drives growth across the CDS portfolio at TFS. As a member of the Executive Committee, Miriam is also responsible for advancing strategic partnerships, aligning commercial functions globally, and advocating for innovative, scalable solutions that meet evolving customer needs.
Miriam brings more than 20 years of experience in clinical research, with a strong background across both sponsor-side and CRO environments. Since joining TFS, she has held progressive leadership roles, including Director, Senior Director, and Head of Business Development for Europe. Throughout her tenure, she has played an integral role in expanding the commercial organization and delivering sustainable sales growth.
Before joining TFS, Miriam held operational roles in clinical research and medical affairs at Bayer, Sanofi, and Coloplast, giving her a broad and practical understanding of sponsor needs and global clinical development operations.
She holds an MBA from the Universitat Politècnica de Catalunya, a degree in Business Administration and Management from the Universitat de Barcelona, and has completed the Business Executive Leadership Program at the Stockholm School of Economics.
Fluent in English, Spanish, and Catalan, Miriam brings a global perspective and people-centered approach to her leadership, driven by a passion for empowering teams and delivering meaningful impact to patients and partners.